ÂÜÀòÂÒÂ×

Yvonne Naughton is an accomplished professional in investor relations and corporate communications, currently serving as the Head of Investor Relations and Corporate Communications at Compugen since June 2021. Prior experience includes nearly 15 years at Sanofi in various leadership roles, where Yvonne successfully enhanced investor engagement and understanding of the company’s pipeline, established the external science strategy for the UK and Ireland, and led market access strategies for key drug products. Previous positions include significant roles at Novartis in medical affairs and safety, as well as at Quintiles in regulatory safety. Yvonne holds a PhD in Pharmacology from University College Dublin and is certified in investor relations by the UK Society of Investor Relations.